tiprankstipranks
Parenteral Drugs (India) Limited (IN:PDPL)
:PDPL
India Market
PDPL
Parenteral Drugs (India) Limited
RESEARCH TOOLSreports

Parenteral Drugs (India) Limited (PDPL) Income Statement

0 Followers

Parenteral Drugs (India) Limited Income Statement

Last quarter (Q4 2022), Parenteral Drugs (India) Limited's total revenue was ₹17.73M, an increase of 143.66% from the same quarter last year. In Q4, Parenteral Drugs (India) Limited's net income was ₹238.13M. See Parenteral Drugs (India) Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 22Mar 21Mar 20Mar 19Mar 17
Total Revenue
₹ 84.96M₹ 121.53M₹ 240.25M₹ 319.98M₹ 2.30B
Gross Profit
₹ 30.31M₹ 48.37M₹ 13.40M₹ 75.64M₹ 519.82M
Operating Expenses
₹ 147.87M₹ 356.03M₹ 329.28M₹ 943.42M₹ 787.91M
Depreciation and Amortization
₹ 401.48M₹ 173.26M₹ 173.46M₹ 691.19M₹ 248.85M
EBITDA
₹ 372.69M₹ -117.09M₹ -144.39M₹ -162.40M₹ -179.85M
Operating Income
₹ -117.56K₹ -82.97K₹ -320.32K₹ -867.78K₹ -1.28B
Other Income/Expenses
₹ -973.70K₹ -1.46M₹ -1.42B₹ -946.19M₹ -1.74B
Pretax Income
₹ -1.09M₹ -1.54M₹ -1.42B₹ -1.81B₹ -1.26B
Net Income
₹ -763.62M₹ -1.22B₹ -1.14B₹ -1.48B₹ -1.15B
Per Share Metrics
Basic EPS
₹ -25.61₹ -40.82₹ -38.26₹ -49.61₹ -38.64
Diluted EPS
₹ -25.61₹ -40.82₹ -38.26₹ -49.61₹ -38.64
Weighted Average Shares Outstanding
 29.82M 29.82M 29.82M 29.82M 29.82M
Weighted Average Shares Outstanding (Diluted)
 29.82M 29.82M 29.82M 29.82M 29.82M
Currency in INR

Parenteral Drugs (India) Limited Earnings and Revenue History